Long-Zhi Decoction Medicated Serum Promotes Angiogenesis in Human Umbilical Vein Endothelial Cells Based on Autophagy

Abstract EN

Ischemic stroke (IS) is a fatal subtype of stroke that lacks effective treatments.

Angiogenesis following IS is an effective response that mediates brain recovery and repair.

Our previous study demonstrated that long-zhi decoction (LZD), a Chinese herbal formula, promoted angiogenesis in rats of IS model.

To further investigate the association between the proangiogenic mechanism of an LZD-medicated serum and cellular autophagy, we evaluated its promotional effect on angiogenesis in human umbilical vein endothelial cells (HUVECs) in vitro.

We used HUVECs subjected to H2O2 to induce injury and observed the effects of the LZD-medicated serum treatment.

Cell-based assays included proliferation, migration, and tube formation.

To assess the extent of autophagy, transmission electron microscopy was used to measure the number of autophagosomes.

Immunofluorescence and Western blotting were performed to evaluate the autophagy-related protein of LC3-II and Beclin-1.

The LZD-medicated serum promoted proliferation, migration, and tube formation in HUVECs.

The LZD-medicated serum also increased the autophagosomes and the autophagic protein expressions of LC3-II and Beclin-1.

The proangiogenic and autophagic activity of LZD provides new cogitations to its clinical application and may lead to potential drug development for treating various vascular diseases, especially in the elderly, in the future.